149 related articles for article (PubMed ID: 28652744)
1. Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report.
Terao T; Ishida A; Kimura T; Yoshida M; Hara T
Neuropsychiatr Dis Treat; 2017; 13():1441-1448. PubMed ID: 28652744
[TBL] [Abstract][Full Text] [Related]
2. A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder.
Zhang L; Zhang H; Lv LX; Tan Q; Xu X; Hu J; Zi L; Cooper J; Phansalkar A; Wang G
Int J Bipolar Disord; 2022 Aug; 10(1):20. PubMed ID: 35909213
[TBL] [Abstract][Full Text] [Related]
3. Spotlight on lamotrigine in bipolar disorder.
Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine: a review of its use in bipolar disorder.
Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review.
Besag FMC; Vasey MJ; Sharma AN; Lam ICH
Ther Adv Psychopharmacol; 2021; 11():20451253211045870. PubMed ID: 34646439
[TBL] [Abstract][Full Text] [Related]
6. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
7. Circadian Rhythm Sleep-Wake Disorders Predict Shorter Time to Relapse of Mood Episodes in Euthymic Patients With Bipolar Disorder: A Prospective 48-Week Study.
Takaesu Y; Inoue Y; Ono K; Murakoshi A; Futenma K; Komada Y; Inoue T
J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29286593
[TBL] [Abstract][Full Text] [Related]
8. Preventive Effects of Lamotrigine in Bipolar II Versus Bipolar I Disorder.
Terao T; Ishida A; Kimura T; Yarita M; Hara T
J Clin Psychiatry; 2017; 78(8):e1000-e1005. PubMed ID: 28817765
[TBL] [Abstract][Full Text] [Related]
9. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
[TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine in patients with bipolar disorder and cocaine dependence.
Brown ES; Nejtek VA; Perantie DC; Orsulak PJ; Bobadilla L
J Clin Psychiatry; 2003 Feb; 64(2):197-201. PubMed ID: 12633129
[TBL] [Abstract][Full Text] [Related]
13. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
[TBL] [Abstract][Full Text] [Related]
14. Effects of lamotrigine in patients with bipolar disorder and alcohol dependence.
Rubio G; López-Muñoz F; Alamo C
Bipolar Disord; 2006 Jun; 8(3):289-93. PubMed ID: 16696832
[TBL] [Abstract][Full Text] [Related]
15. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials.
Frye MA; Yatham LN; Calabrese JR; Bowden CL; Ketter TA; Suppes T; Adams BE; Thompson TR
J Clin Psychiatry; 2006 Nov; 67(11):1721-8. PubMed ID: 17196051
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
[TBL] [Abstract][Full Text] [Related]
17. A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
McElroy SL; Zarate CA; Cookson J; Suppes T; Huffman RF; Greene P; Ascher J
J Clin Psychiatry; 2004 Feb; 65(2):204-10. PubMed ID: 15003074
[TBL] [Abstract][Full Text] [Related]
18. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
Redmond JR; Jamison KL; Bowden CL
CNS Spectr; 2006 Dec; 11(12):915-8. PubMed ID: 17146405
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
